The global Cell Culture Market is experiencing significant growth as pharmaceutical and biotechnology companies increasingly rely on cell culture technologies for biopharmaceutical production, drug development, regenerative medicine, and scientific research. The market size is expected to reach US$ 61.12 billion by 2031. The market is anticipated to register a CAGR of 10.7% during...

The global animal genetics market is witnessing steady growth, supported by advancements in biotechnology, increasing demand for animal-derived food products, and the growing adoption of advanced genetic testing techniques. Animal genetics plays an important role in improving livestock productivity, animal health, breeding efficiency, and genetic characteristics. The animal genetics market was...

The global animal genetics market is witnessing steady growth, supported by advancements in biotechnology, increasing demand for animal-derived food products, and the growing adoption of advanced genetic testing techniques. Animal genetics plays an important role in improving livestock productivity, animal health, breeding efficiency, and genetic characteristics. The animal genetics market was...

Across North America, the market benefits from integrated industrial supply chains, robust commercial construction activity, and expanding mining and energy developments in Canada and Mexico. Regional demand is characterized by high adoption of hot-dip galvanized and heavy-duty steel gratings engineered to withstand extreme weather conditions, high impact load, and corrosive chemical...

The global Antimicrobial Agents Market was valued at US$ 3.07 billion in 2025 and is projected to reach US$ 6.15 billion by 2034, registering a compound annual growth rate (CAGR) of 6.87% during 2026–2034. The market is experiencing growing demand due to the rising incidence of infectious diseases, advancements in drug development, and increasing government and regulatory support. The...

The global Antimicrobial Agents Market was valued at US$ 3.07 billion in 2025 and is projected to reach US$ 6.15 billion by 2034, registering a compound annual growth rate (CAGR) of 6.87% during 2026–2034. The market is experiencing growing demand due to the rising incidence of infectious diseases, advancements in drug development, and increasing government and regulatory support. The...